FDA Alert: Johnson & Johnson 1-Dose Shot Prevents CCP Virus

Tyrone Valiant, 73, receives a Band-Aid after being administered a dose of the Moderna COVID-19 vaccine by a health care worker outside the Los Angeles Mission located in the Skid Row community in Los Angeles on Feb. 10, 2021. Mario Tama/Getty Images

The Food and Drug Administration (FDA) stated on Feb. 24 that Johnson & Johnson’s single-dose vaccine prevents COVID-19 and that the FDA will make a final authorization decision soon.

Johnson & Johnson has an ongoing study of 44,000 patients in South Africa, the United States, and several other countries, with seven deaths recorded among patients receiving a placebo—and none among those who got the vaccine.